Long-term survival after gastrectomy and metastasectomy for gastric cancer with synchronous bone metastasis

World J Gastroenterol. 2018 Jan 7;24(1):150-156. doi: 10.3748/wjg.v24.i1.150.

Abstract

Bone metastasis is a rare event in patients with gastric cancer, but pathologic fracture, paralysis, pain and hematological disorders associated with the bone metastasis may influence the quality of life. We report herein the case of a 53-year-old man who presented with primary remnant gastric cancer with bone metastasis. The patient requested further investigations after detection of a metastatic lesion in the 2nd lumbar vertebra during evaluation for back pain that had persisted for 3 mo. No other metastatic lesions were detected. He underwent total gastrectomy and palliative metastasectomy to aid in reduction of symptoms, and he received combination chemotherapy with tegafur (S-1) and cisplatin. The patient survived for about 60 mo after surgery. Currently, there is no treatment guideline for gastric cancer with bone metastasis, and we believe that gastrectomy plus metastasectomy may be an effective therapeutic option for improving quality of life and survival in patients with resectable primary gastric cancer and bone metastasis.

Keywords: Bone neoplasms; Gastrectomy; Metastasectomy; Neoplasm metastasis; Stomach neoplasms.

Publication types

  • Case Reports

MeSH terms

  • Chemotherapy, Adjuvant
  • Fatal Outcome
  • Gastrectomy*
  • Gastroscopy
  • Humans
  • Lumbar Vertebrae / pathology
  • Lumbar Vertebrae / surgery*
  • Magnetic Resonance Imaging
  • Male
  • Metastasectomy / methods*
  • Middle Aged
  • Osteotomy*
  • Spinal Neoplasms / secondary
  • Spinal Neoplasms / surgery*
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Time Factors
  • Treatment Outcome